Compare IDEXX Laboratories, Inc. (IDXX) vs Iron Mountain Inc (IRM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Iron Mountain Inc — how do they compare? IDEXX Laboratories, Inc. trades at $563.81 (market cap $44.48B), while Iron Mountain Inc trades at $126.09 (market cap $36.96B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and Iron Mountain Inc pays a 2.78% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | IRM | |
|---|---|---|
Market Cap | $44.48B | $36.96B |
Sector | Health | Real Estate |
52-Week High | $766.68 | $133.06 |
52-Week Low | $520.87 | $78.86 |
Enterprise Value | $45.38B | $56.10B |
Dividend Yield | — | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories trades at $552.46, down 2.64% today, with neutral technical signals but strong fundamental performance. The company maintains robust profitability with 24.63% net margins and has beaten earnings expectations for three consecutive quarters. Recent news highlights AI integration in medical devices and upcoming Q2 2026 results on August 4, 2026. The stock shows consistent revenue growth from $3.4B in 2022 to $4.3B in 2025.
Outlook remains positive given earnings momentum and analyst consensus, though elevated valuation ratios (P/E 41.49) pose risks. Key catalysts include Q2 earnings release and continued AI adoption in veterinary diagnostics. Primary risks involve competitive pressures and market volatility affecting premium valuations.
Iron Mountain (IRM) trades at $125.56, up 1.41% today, near its recent highs. The stock shows strong momentum with a bullish technical signal and consistent earnings beats. Revenue grew to $6.90B in 2025, though net margins are thin at 3.76%. High debt levels and a P/E of 135.03 present valuation concerns, but analyst consensus is bullish with a $140.50 price target. Recent news highlights institutional activity and data center growth potential.
Outlook remains positive driven by recurring revenue streams and data center expansion, but investors face risks from elevated leverage and interest expenses. The stock offers growth exposure with a dividend, yet requires monitoring of debt management and competitive pressures in information services.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Iron Mountain Inc
Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →
